comparemela.com

Gailb Cohen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Theravance Biopharma, Inc Initiates $250 Million Capital Return Program

/PRNewswire/ Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) announced today that its Board of Directors has authorized.

Theravance biopharmaGailb cohenCorporate communicationsPrnewswire theravance biopharma incTheravance biopharma incSecurities exchangeViatris companyOpen market share repurchase planOpen market stock repurchase planInformation regardingTender offer statementTender offerPrivate securities litigation reform actSecurities exchange act

Theravance Biopharma, Inc Reports Second Quarter 2022 Financial Results and Provides Business Update

Highest quarter of YUPELRI® (revefenacin) net sales and profitability to date1: $17.2M Q2 2022 sales up 17% from Q2 2021 (implied 35% share) Ampreloxetine.

Ricke winninghamTheravance biopharmaGailb cohenTheravance biopharma incCompany tender offer statement on scheduleCompany annual report on formDevelopment rd expensesTheravance respiratory companyCorporate communicationsSecurities exchangePrnewswire theravance biopharma incViatris companyWhile viatris incMultiple system atrophyRoyalty pharmaConvertible senior

Theravance Biopharma to Report Second Quarter 2022 Financial Results on August 4, 2022

/PRNewswire/ Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2022 financial results and provide a business update after market.

Theravance biopharmaGailb cohenCorporate communicationsTheravance biopharma incPrnewswire theravance biopharma incViatris company

Theravance Biopharma, Inc Reports First Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the first quarter of.

United statesRicke winninghamTheravance biopharmaGailb cohenGlaxo groupTheravance biopharma incCompany annual report on formCompany formDevelopment rd expensesTheravance respiratory companyInnoviva incCorporate communicationsPrnewswire theravance biopharma incSecurities exchangeWhile viatris incViatris company

Theravance Biopharma to Participate in an Upcoming Investor Conference

/PRNewswire/ Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, at 1:30.

Theravance biopharmaGailb cohenInnoviva incGlaxo groupCorporate communicationsTheravance biopharma incPrnewswire theravance biopharma incViatris companyAnnual needham virtual healthcare conferenceGlaxo group limited

vimarsana © 2020. All Rights Reserved.